US6927044B2
(en)
*
|
1998-09-25 |
2005-08-09 |
Regeneron Pharmaceuticals, Inc. |
IL-1 receptor based cytokine traps
|
US20090137416A1
(en)
*
|
2001-01-16 |
2009-05-28 |
Regeneron Pharmaceuticals, Inc. |
Isolating Cells Expressing Secreted Proteins
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
US20040224893A1
(en)
*
|
2003-05-06 |
2004-11-11 |
Li-Hsien Wang |
Methods of using IL-1 antagonists to treat neointimal hyperplasia
|
EP3095793B1
(fr)
*
|
2003-07-28 |
2020-03-25 |
Genentech, Inc. |
Réduction de protéine a pendant une chromatographie d'affinité sur protéine a
|
US20050129685A1
(en)
*
|
2003-09-18 |
2005-06-16 |
Jingtai Cao |
Use of IL-1 blockers to prevent corneal inflammation and neovascularization
|
WO2005037869A2
(fr)
*
|
2003-10-15 |
2005-04-28 |
Applera Corporation |
Methode de diminution de lixiviat de milieux d'affinite a la proteine a
|
EP1723173B1
(fr)
|
2004-02-27 |
2008-05-14 |
Regeneron Pharmaceuticals, Inc. |
Polypeptides specifiques d'il-4/il-13 et utilisations therapeutiques associees
|
CN1964737B
(zh)
*
|
2004-06-04 |
2011-04-20 |
瑞泽恩制药公司 |
利用il-1拮抗剂治疗自身炎症性疾病的方法
|
US7655758B2
(en)
|
2004-08-17 |
2010-02-02 |
Regeneron Pharmaceuticals, Inc. |
Stable liquid IL-1 antagonist formulations
|
US7572893B2
(en)
*
|
2004-08-17 |
2009-08-11 |
Regeneron Pharmaceuticals, Inc. |
IL-1 antagonist formulations
|
EP2311871A3
(fr)
|
2004-08-17 |
2012-08-08 |
Regeneron Pharmaceuticals, Inc. |
Composition liquide stable comprenant des antagonistes de IL-1
|
US20060160737A1
(en)
*
|
2005-01-14 |
2006-07-20 |
Allen Radin |
Methods of using IL-1 antagonists to treat polymyalgia rheumatica and giant cell arteritis
|
US20060171948A1
(en)
*
|
2005-02-02 |
2006-08-03 |
Weinstein Steven P |
Methods of using IL-1 antagonists to reduce C-reactive protein
|
US20100015146A1
(en)
*
|
2005-10-14 |
2010-01-21 |
Novo Nordisk A/S |
Treating diabetes using inhibitors of il-1
|
US7632490B2
(en)
*
|
2006-10-20 |
2009-12-15 |
Regeneron Pharmaceuticals, Inc. |
Use of IL-1 antagonists to treat gout
|
NZ575972A
(en)
*
|
2006-10-20 |
2011-01-28 |
Regeneron Pharma |
Use of il-1 antagonists to treat gout and pseudogout
|
WO2008093756A1
(fr)
*
|
2007-01-30 |
2008-08-07 |
Niigata University |
Préparation biologique
|
KR101709495B1
(ko)
|
2007-08-10 |
2017-02-23 |
리제너론 파아마슈티컬스, 인크. |
인간 신경성장인자에 대한 고친화성 인간 항체
|
US10105441B2
(en)
*
|
2007-08-16 |
2018-10-23 |
The Schepens Eye Research Institute, Inc. |
Method for inhibiting or reducing dry eye disease by IL-1Ra
|
US8753690B2
(en)
|
2008-02-27 |
2014-06-17 |
Biomet Biologics, Llc |
Methods and compositions for delivering interleukin-1 receptor antagonist
|
EP2620139B1
(fr)
|
2008-02-27 |
2016-07-20 |
Biomet Biologics, LLC |
Solutions riches d'un antagoniste du récepteur de l'interleukine-1
|
US8828354B2
(en)
*
|
2008-03-27 |
2014-09-09 |
Warsaw Orthopedic, Inc. |
Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
|
US9072727B2
(en)
|
2008-04-18 |
2015-07-07 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of degenerative disc disease
|
US8557273B2
(en)
*
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
US9125917B2
(en)
|
2008-04-18 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Fluocinolone formulations in a biodegradable polymer carrier
|
US8956636B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprosing ketorolac
|
US8889173B2
(en)
|
2008-04-18 |
2014-11-18 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
|
US8629172B2
(en)
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
US9289409B2
(en)
*
|
2008-04-18 |
2016-03-22 |
Warsaw Orthopedic, Inc. |
Sulindac formulations in a biodegradable material
|
US20090263451A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
|
US20090264489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
|
US9132085B2
(en)
|
2008-04-18 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating post-operative pain using clonidine and bupivacaine
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
US8722079B2
(en)
|
2008-04-18 |
2014-05-13 |
Warsaw Orthopedic, Inc. |
Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
|
US8846068B2
(en)
|
2008-04-18 |
2014-09-30 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising a local anesthetic
|
US8420114B2
(en)
*
|
2008-04-18 |
2013-04-16 |
Warsaw Orthopedic, Inc. |
Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
|
US20090263443A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedics, Inc. |
Methods for treating post-operative effects such as spasticity and shivering with clondine
|
US9132119B2
(en)
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
US8956641B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of inflammatory diseases
|
US20090264477A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc., An Indiana Corporation |
Beta adrenergic receptor agonists for treatment of pain and/or inflammation
|
US20100016265A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Qaiser Yusuf |
Anti-inflammatory composition and method for preparation
|
US20100015049A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
|
US9492375B2
(en)
|
2008-07-23 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Foam carrier for bone grafting
|
WO2010013498A1
(fr)
*
|
2008-08-01 |
2010-02-04 |
学校法人聖マリアンナ医科大学 |
Agent thérapeutique ou agent préventif pour l'arthrose
|
US9161903B2
(en)
*
|
2008-10-31 |
2015-10-20 |
Warsaw Orthopedic, Inc. |
Flowable composition that hardens on delivery to a target tissue site beneath the skin
|
AU2010203425B2
(en)
*
|
2009-01-09 |
2015-04-09 |
The Schepens Eye Research Institute, Inc. |
Therapeutic compositions for treatment of corneal disorders
|
US20100226959A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Matrix that prolongs growth factor release
|
US20100228097A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Methods and compositions to diagnose pain
|
US20100239632A1
(en)
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
US8617583B2
(en)
|
2009-07-17 |
2013-12-31 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
|
US8231891B2
(en)
|
2009-07-31 |
2012-07-31 |
Warsaw Orthopedic, Inc. |
Implantable drug depot for weight control
|
CA2772084C
(fr)
|
2009-08-27 |
2016-10-18 |
Biomet Biologics, Llc |
Dispositif implantable pour la production d'antagoniste de recepteur d'interleukine-1
|
US20110052561A1
(en)
|
2009-08-27 |
2011-03-03 |
Biomet Biologics,LLC |
Osteolysis treatment
|
CA2774999A1
(fr)
|
2009-09-30 |
2011-04-07 |
President And Fellows Of Harvard College |
Procedes de modulation de l'autophagie par la modulation de produits geniques renforcant l'autophagie
|
US20110097375A1
(en)
|
2009-10-26 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Formulation for preventing or reducing bleeding at a surgical site
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
US9504698B2
(en)
*
|
2009-10-29 |
2016-11-29 |
Warsaw Orthopedic, Inc. |
Flowable composition that sets to a substantially non-flowable state
|
US8597192B2
(en)
|
2009-10-30 |
2013-12-03 |
Warsaw Orthopedic, Inc. |
Ultrasonic devices and methods to diagnose pain generators
|
US8475824B2
(en)
|
2010-01-26 |
2013-07-02 |
Warsaw Orthopedic, Inc. |
Resorbable matrix having elongated particles
|
US8758791B2
(en)
|
2010-01-26 |
2014-06-24 |
Warsaw Orthopedic, Inc. |
Highly compression resistant matrix with porous skeleton
|
US9125902B2
(en)
*
|
2010-01-28 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Methods for treating an intervertebral disc using local analgesics
|
US9050274B2
(en)
*
|
2010-01-28 |
2015-06-09 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents
|
US9486500B2
(en)
|
2010-01-28 |
2016-11-08 |
Warsaw Orthopedic, Inc. |
Osteoimplant and methods for making
|
JO3183B1
(ar)
|
2010-01-29 |
2018-03-08 |
Regeneron Pharma |
طرق لمعالجة أمراض المناعة الذاتية مضادات dll4
|
JP2012246222A
(ja)
*
|
2010-01-29 |
2012-12-13 |
Axis Inc |
変形性関節症治療剤または予防剤を製造するための使用
|
EP2552967A4
(fr)
|
2010-04-02 |
2014-10-08 |
Amunix Operating Inc |
Protéines de fusion liantes, conjugués protéines de fusion liantes-médicaments, conjugués xten-médicaments et procédés pour les préparer et les utiliser
|
KR20140002601A
(ko)
|
2010-07-09 |
2014-01-08 |
바이오겐 이데크 헤모필리아 인코포레이티드 |
키메라 응고 인자
|
EP2598526B1
(fr)
|
2010-07-29 |
2018-09-05 |
Eleven Biotherapeutics, Inc. |
Agonistes et antagonistes chimeriques du recepteur d'il-1 type i
|
US8246571B2
(en)
|
2010-08-24 |
2012-08-21 |
Warsaw Orthopedic, Inc. |
Drug storage and delivery device having a retaining member
|
AU2011296356B2
(en)
|
2010-09-03 |
2015-07-09 |
Biomet Biologics, Llc |
Methods and compositions for delivering interleukin-1 receptor antagonist
|
US9414930B2
(en)
|
2010-10-26 |
2016-08-16 |
Kyphon SÀRL |
Activatable devices containing a chemonucleolysis agent
|
US8740982B2
(en)
|
2010-10-26 |
2014-06-03 |
Kyphon Sarl |
Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
|
US8404268B2
(en)
|
2010-10-26 |
2013-03-26 |
Kyphon Sarl |
Locally targeted anti-fibrotic agents and methods of use
|
JO3375B1
(ar)
|
2010-11-08 |
2019-03-13 |
Regeneron Pharma |
أجسام مضادة بشرية للجين a1 الشبيه بعامل النخر الورمي (tl1a)
|
US9301946B2
(en)
|
2010-12-03 |
2016-04-05 |
Warsaw Orthopedic, Inc. |
Clonidine and GABA compounds in a biodegradable polymer carrier
|
WO2012075447A2
(fr)
|
2010-12-03 |
2012-06-07 |
Warsaw Orthopedic, Inc. |
Compositions et méthodes d'administration de clonidine et de bupivacaïne en direction d'un tissu cible
|
US9060978B2
(en)
|
2011-01-24 |
2015-06-23 |
Warsaw Orthopedic, Inc. |
Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
|
US9717779B2
(en)
|
2011-01-31 |
2017-08-01 |
Warsaw Orthopedic, Inc. |
Implantable matrix having optimum ligand concentrations
|
US20140308294A1
(en)
|
2011-04-15 |
2014-10-16 |
Merck Patent Gmbh |
Anti-IL-1R1 Inhibitors For Use in Cancer
|
US9592243B2
(en)
|
2011-04-25 |
2017-03-14 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for treatment of an injury
|
US9511077B2
(en)
|
2011-04-25 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for wound healing
|
US9132194B2
(en)
|
2011-07-12 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive sheet containing a drug depot
|
US9205241B2
(en)
|
2011-07-12 |
2015-12-08 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive material
|
AU2012339722B2
(en)
|
2011-11-14 |
2017-09-14 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and/or Activin A
|
IL303832A
(en)
|
2011-11-18 |
2023-08-01 |
Regeneron Pharma |
Microparticles of polymeric proteins
|
CN104271150A
(zh)
|
2012-01-12 |
2015-01-07 |
比奥根艾迪克Ma公司 |
嵌合因子viii多肽及其用途
|
US9511018B2
(en)
|
2012-04-05 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable matrix
|
US8735504B2
(en)
|
2012-05-02 |
2014-05-27 |
Warsaw Orthopedic, Inc. |
Methods for preparing polymers having low residual monomer content
|
CN103509100B
(zh)
*
|
2012-06-15 |
2017-10-27 |
上海百迈博制药有限公司 |
一种白细胞介素‑1受体拮抗剂突变体
|
PL3470432T3
(pl)
|
2012-08-21 |
2022-02-07 |
Sanofi Biotechnology |
Sposoby leczenia lub zapobiegania astmie przez podawanie antagonisty IL-4R
|
JO3462B1
(ar)
|
2012-08-22 |
2020-07-05 |
Regeneron Pharma |
أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها
|
WO2014035361A1
(fr)
*
|
2012-08-26 |
2014-03-06 |
R-PHARM, CJSC (Closed Joint Stock Company) |
Composition d'inhibiteur de l'il-1β et son utilisation
|
AU2013312868B2
(en)
|
2012-09-07 |
2018-03-22 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating atopic dermatitis by administering an IL-4R antagonist
|
TWI675044B
(zh)
|
2012-11-14 |
2019-10-21 |
美商再生元醫藥公司 |
重組細胞表面捕捉蛋白質
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
KR101989551B1
(ko)
|
2013-02-15 |
2019-09-30 |
알-팜 인터내셔널, 엘엘씨. |
IL-1β 억제제 조성물 및 이의 용도
|
DK2968468T3
(en)
|
2013-03-13 |
2021-07-26 |
Buzzard Pharmaceuticals AB |
Chimeric cytokine formulations for ocular delivery
|
EA201591754A1
(ru)
|
2013-03-14 |
2016-01-29 |
Ридженерон Фармасьютикалз, Инк. |
Человеческие антитела к na1.7
|
UY35463A
(es)
|
2013-03-15 |
2014-10-31 |
Biogen Idec Inc |
Formulaciones de polipéptido fc-factor ix.
|
US9758806B2
(en)
|
2013-03-15 |
2017-09-12 |
Biomet Biologics, Llc |
Acellular compositions for treating inflammatory disorders
|
US9895418B2
(en)
|
2013-03-15 |
2018-02-20 |
Biomet Biologics, Llc |
Treatment of peripheral vascular disease using protein solutions
|
US10208095B2
(en)
|
2013-03-15 |
2019-02-19 |
Biomet Manufacturing, Llc |
Methods for making cytokine compositions from tissues using non-centrifugal methods
|
US20140271589A1
(en)
|
2013-03-15 |
2014-09-18 |
Biomet Biologics, Llc |
Treatment of collagen defects using protein solutions
|
US9950035B2
(en)
|
2013-03-15 |
2018-04-24 |
Biomet Biologics, Llc |
Methods and non-immunogenic compositions for treating inflammatory disorders
|
US9878011B2
(en)
|
2013-03-15 |
2018-01-30 |
Biomet Biologics, Llc |
Treatment of inflammatory respiratory disease using biological solutions
|
SG11201507429TA
(en)
|
2013-03-15 |
2015-10-29 |
Genentech Inc |
Il-22 polypeptides and il-22 fc fusion proteins and methods of use
|
US10143725B2
(en)
|
2013-03-15 |
2018-12-04 |
Biomet Biologics, Llc |
Treatment of pain using protein solutions
|
CA2911547A1
(fr)
*
|
2013-05-31 |
2014-12-04 |
Regeneron Pharmaceuticals, Inc. |
Methodes d'utilisation d'antagonistes de l'il-1 pour traiter la maladie d'alzheimer
|
SI3010539T1
(sl)
|
2013-06-21 |
2019-11-29 |
Regeneron Pharma |
Postopki za zdravljenje nazalne polipoze z administriranjem antagonista IL-4R
|
EP3074507B1
(fr)
|
2013-11-26 |
2022-01-05 |
Biomet Biologics, LLC |
Procédés de médiation des phénotypes macrophagiques
|
CN106232140A
(zh)
|
2014-02-21 |
2016-12-14 |
赛诺菲生物技术公司 |
通过施用il‑4r拮抗剂治疗或预防哮喘的方法
|
US11155600B2
(en)
*
|
2014-03-24 |
2021-10-26 |
R-Pharm Overseas, Inc. |
Human IL1-R1 derived inhibitor of IL-1β
|
US20210403534A1
(en)
*
|
2014-03-24 |
2021-12-30 |
R-Pharm Overseas, Inc. |
IL1-R1 DERIVED INHIBITOR OF IL-1b AND USE THEREOF
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
US10441635B2
(en)
|
2014-11-10 |
2019-10-15 |
Biomet Biologics, Llc |
Methods of treating pain using protein solutions
|
WO2016077675A1
(fr)
|
2014-11-14 |
2016-05-19 |
Sanofi Biotechnology |
Méthodes de traitement de la sinusite chronique avec polypose nasale par administration d'un antagoniste d'il-4r
|
EP3253875B1
(fr)
|
2015-02-04 |
2020-01-08 |
H. Hoffnabb-La Roche Ag |
Oligomères antisens de la protéine tau et leurs utilisations
|
CN107636159B
(zh)
|
2015-02-04 |
2022-06-14 |
百时美施贵宝公司 |
选择治疗性分子的方法
|
GB201503453D0
(en)
|
2015-03-01 |
2015-04-15 |
Jain Arjun |
Endothelin-1"sponge"
|
AU2016227458A1
(en)
*
|
2015-03-01 |
2018-08-02 |
Arjun Jain |
Endothelin-1 receptor based endothelin-1 sponge
|
US9763800B2
(en)
|
2015-03-18 |
2017-09-19 |
Biomet C. V. |
Implant configured for hammertoe and small bone fixation
|
MA41919A
(fr)
|
2015-04-06 |
2018-02-13 |
Acceleron Pharma Inc |
Hétéromultimères alk4:actriib et leurs utilisations
|
EP3889171A1
(fr)
|
2015-04-06 |
2021-10-06 |
Acceleron Pharma Inc. |
Hétéromultimères de récepteur de type i et de type ii de la superfamille de tgf-bêta et leurs utilisations
|
EA201792298A1
(ru)
|
2015-04-15 |
2018-04-30 |
Регенерон Фармасьютикалз, Инк. |
Способы увеличения силы и функциональности с помощью ингибиторов gdf8
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
CN108366968B
(zh)
|
2015-12-16 |
2022-02-18 |
瑞泽恩制药公司 |
制造蛋白质微粒的组合物和方法
|
USD802757S1
(en)
|
2016-06-23 |
2017-11-14 |
Warsaw Orthopedic, Inc. |
Drug pellet cartridge
|
DK3761035T3
(da)
|
2016-08-18 |
2024-03-11 |
Regeneron Pharma |
Analyse til bestemmelse af et proteins potentiale til selvassociering ved hjælp af koncentrationsafhængig selvinteraktionsnanopartikelspektroskopi
|
CA3035202A1
(fr)
|
2016-09-01 |
2018-03-08 |
Regeneron Pharmaceuticals, Inc. |
Methodes de prevention ou de traitement de l'allergie par administration d'un antagoniste d'il-4 r
|
CA3039573A1
(fr)
|
2016-10-05 |
2018-04-12 |
Acceleron Pharma Inc. |
Heteromultimeres alk4:actriib et leurs utilisations
|
MY197672A
(en)
|
2016-10-07 |
2023-07-03 |
Regeneron Pharma |
Room temperature stable lyophilized protein
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
CA3045116A1
(fr)
|
2016-11-29 |
2018-06-07 |
Regeneron Pharmaceuticals, Inc. |
Composition pharmaceutique destinee a prevenir une dependance aux opioides
|
TWI784988B
(zh)
|
2016-12-01 |
2022-12-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
US20200158716A1
(en)
*
|
2017-07-17 |
2020-05-21 |
Massachusetts Institute Of Technology |
Cell atlas of healthy and diseased barrier tissues
|
HUE064655T2
(hu)
|
2017-10-30 |
2024-04-28 |
Sanofi Biotechnology |
IL-4R antagonista asztma kezelésére vagy megelõzésére szolgáló eljárásban
|
MA52417A
(fr)
|
2018-03-01 |
2021-01-06 |
Regeneron Pharma |
Procédés de modification de composition corporelle
|
AU2019270184A1
(en)
|
2018-05-18 |
2020-11-26 |
Bioverativ Therapeutics Inc. |
Methods of treating hemophilia A
|
MX2021001549A
(es)
|
2018-08-10 |
2021-04-13 |
Regeneron Pharma |
Una composicion farmaceutica para el tratamiento seguro y efectivo del dolor de rodilla y/o cadera.
|
EP3941589A1
(fr)
|
2019-03-21 |
2022-01-26 |
Regeneron Pharmaceuticals, Inc. |
Combinaison d'inhibiteurs de la voie il-4/il-13 et d'ablation de plasmocytes pour traiter une allergie
|
BR112021021195A2
(pt)
|
2019-05-01 |
2022-03-03 |
Regeneron Pharma |
Métodos para tratamento ou prevenção da asma pela administração de um antagonista de il-33
|
WO2021011614A1
(fr)
|
2019-07-16 |
2021-01-21 |
Sanofi Biotechnology |
Méthodes de traitement ou de prévention de l'asthme par administration d'un antagoniste d'il-4r
|
KR20220110553A
(ko)
|
2019-12-06 |
2022-08-08 |
사노피 바이오테크놀로지 |
Il-33 길항제를 투여하여 copd를 치료하는 방법
|
AU2020415382A1
(en)
|
2019-12-23 |
2022-08-18 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating or preventing allergic asthma by administering an IL-33 antagonist and/or an IL-4R antagonist
|
JP2023515270A
(ja)
|
2020-04-21 |
2023-04-12 |
テンパス・ラボズ・インコーポレイテッド |
Tcr/bcrプロファイリング
|
EP4225436A1
(fr)
|
2020-10-05 |
2023-08-16 |
Sanofi Biotechnology |
Méthodes de traitement de l'asthme chez des sujets pédiatriques par administration d'un antagoniste d'il-4r
|
CA3191141A1
(fr)
|
2020-11-25 |
2022-06-02 |
Hunter Chen |
Formulations a liberation prolongee a l'aide d'une emulsification par membrane non aqueuse
|
KR20230134117A
(ko)
|
2021-01-20 |
2023-09-20 |
리제너론 파마슈티칼스 인코포레이티드 |
세포 배양물에서 단백질 역가를 개선시키는 방법
|
CA3207883A1
(fr)
|
2021-03-03 |
2022-09-09 |
Xiaobin Xu |
Systemes et procedes de quantification et de modification de la viscosite de proteines
|
MX2023014246A
(es)
|
2021-06-01 |
2024-01-17 |
Regeneron Pharma |
Ensayos y reactivos de microchips de electroforesis capilar.
|
CA3226781A1
(fr)
|
2021-07-26 |
2023-02-02 |
Nikhil AMIN |
Methodes de traitement de l'urticaire spontanee chronique par administration d'un antagoniste de l'il-4r
|
US20230077710A1
(en)
|
2021-09-08 |
2023-03-16 |
Regeneron Pharmaceuticals, Inc. |
HIGH-THROUGHPUT AND MASS-SPECTROMETRY-BASED METHOD FOR QUANTITATING ANTIBODIES AND OTHER Fc-CONTAINING PROTEINS
|
IL312187A
(en)
|
2021-10-20 |
2024-06-01 |
Regeneron Pharma |
Methods for treating prurigo nodularis by administering an IL-4R antagonist
|
KR20240097864A
(ko)
|
2021-10-26 |
2024-06-27 |
리제너론 파마슈티칼스 인코포레이티드 |
상이한 온도에서 실험실 용수를 생성하고 실험실 용수를 분배하는 시스템 및 방법
|
WO2023092052A1
(fr)
|
2021-11-19 |
2023-05-25 |
Regeneron Pharmaceuticals, Inc. |
Méthodes et compositions pour réduire la douleur centralisée
|
WO2023169686A1
(fr)
|
2022-03-10 |
2023-09-14 |
Buzzard Pharmaceuticals AB |
Inhibiteur du récepteur de l'interleukine-1 de type 1 destiné à être utilisé dans le traitement du cancer
|
WO2023212586A1
(fr)
|
2022-04-27 |
2023-11-02 |
Regeneron Pharmaceuticals, Inc. |
Procédés de sélection de patients pour le traitement avec un antagoniste du ngf
|
WO2024047021A1
(fr)
|
2022-08-29 |
2024-03-07 |
Sanofi |
Méthodes de traitement de l'urticaire au froid inductible chronique par administration d'un antagoniste de l'il-4r
|